Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don M Benson

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Blood|December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibodyFarrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
The Journal of Clinical Investigation|March 3, 2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and humanJianhua Yu, Takeki Mitsui, Min Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 26, 2021
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic MalignancyAshley E Rosko, Sarah Wall, Robert Baiocchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2016
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host DiseaseSumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2016
Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668]Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Blood|May 13, 2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibodyDon M Benson, Courtney E Bakan, Anjali Mishra, et al.
ACS Omega|August 4, 2025
Design, Synthesis, and Evaluation of Aza-Peptide Michael Acceptors as Human 20S Proteasome Inhibitors: Extension to the Prime SiteSarah E Border, Leilani M Lotti Diaz, Rasmiah Amer, et al.
The Journal of Biological Chemistry|October 27, 2016
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia CellsKavin Fatehchand, Elizabeth L McMichael, Brenda F Reader, et al.
Frontiers in Oncology|March 14, 2022
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell TransplantAudrey M Sigmund, Qiuhong Zhao, Justin Jiang, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Blood|December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibodyFarrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
The Journal of Clinical Investigation|March 3, 2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and humanJianhua Yu, Takeki Mitsui, Min Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 26, 2021
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic MalignancyAshley E Rosko, Sarah Wall, Robert Baiocchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2016
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host DiseaseSumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2016
Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668]Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Blood|May 13, 2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibodyDon M Benson, Courtney E Bakan, Anjali Mishra, et al.
ACS Omega|August 4, 2025
Design, Synthesis, and Evaluation of Aza-Peptide Michael Acceptors as Human 20S Proteasome Inhibitors: Extension to the Prime SiteSarah E Border, Leilani M Lotti Diaz, Rasmiah Amer, et al.
The Journal of Biological Chemistry|October 27, 2016
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia CellsKavin Fatehchand, Elizabeth L McMichael, Brenda F Reader, et al.
Frontiers in Oncology|March 14, 2022
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell TransplantAudrey M Sigmund, Qiuhong Zhao, Justin Jiang, et al.
Pageof 11